Business Standard

We didn't delay vaccine results until after US election, says Pfizer CEO

Last week, Pfizer and BioNTech said their vaccine was more than 90% effective at preventing Covid-19, based on an initial analysis

Pfizer
Premium

Bourla had originally suggested the companies would have vaccine results by the end of October, but did not release the findings until Nov. 9, nearly a week after the election

Reuters
Pfizer Inc "didn't conspire with anyone" to delay release of efficacy results for the Covid-19 vaccine it developed with German partner BioNTech SE until after the U.S. presidential election, Chief Executive Albert Bourla said on Tuesday.

"The elections were always for us an artificial line. It may have been very important for the president but not for us," Bourla said at New York Times event. "I didn't receive any pressure per se on me to do something that was not appropriate ... I would never do something like that," he said.

Last week, Pfizer and BioNTech said their vaccine was more than

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in